Gottlieb gets a new gig

May 24, 2019

Former FDA Commissioner Dr. Scott Gottlieb has been named a special partner at a venture capital firm with a major health care investment portfolio, after unexpectedly departing from his position as the country’s top drug regulator this past March.

Gottlieb will rejoin New Enterprise Associates, where he previously had a 10-year tenure as a venture partner. According to NEA, "Scott will be based in our Chevy Chase, Maryland, office and will be an active investor across the full spectrum of our healthcare activities, with a particular emphasis on biopharma and healthcare services."

Gottlieb left his FDA post after less than two years, saying he wanted to spend more time with his family.

Read the New Enterprise Associates press release